In our previous study, in which activated immune cells were transferred to immunodeficient mice with brain metastases, the enhanced anti-tumor effect of anti-PD-L1 was suggested to be due to the intratumoral activation of tumor-infiltrating CD8+ T cells [24]. This evidence concerns the gene CD8A and neoplasm.